Sinovac Biotech (SVA) has disclosed that the Judicial Committee of the Privy Council in London has determined that the slate of nominees suggested by a group of shareholders during the 2018 Annual General Meeting is the legitimately elected Board of SINOVAC. Furthermore, the Privy Council declared the Rights Agreement to be null and void.
SINOVAC emphasized that the departing Board members are committed to facilitating a seamless transition to the new Board members. This ruling will be enacted once a court order is officially filed.
